Mepro Pharmaceuticals Private Limited — Pyrantel Exporter Profile
Indian Pharmaceutical Exporter · #5 for Pyrantel · $166.6K export value · DGFT Verified
Mepro Pharmaceuticals Private Limited is the #5 Indian exporter of Pyrantel with $166.6K in export value and 13 verified shipments. Mepro Pharmaceuticals Private Limited holds a 5.1% market share in Pyrantel exports across 3 countries. The company exports 11 pharmaceutical products worth $17.5M across 6 therapeutic categories.
Mepro Pharmaceuticals Private Limited — Pyrantel Export Profile: Buyers & Destinations

Where Does Mepro Pharmaceuticals Private Limited Export Pyrantel?
| Country | Value | Shipments | Share |
|---|---|---|---|
| CONGO | $54.5K | 3 | 32.7% |
| CONGO, THE DEMOCRATIC REPUBLIC OF THE | $53.0K | 5 | 31.8% |
| CONGO THE DEMOCRATIC REPUBLIC OF THE | $45.5K | 4 | 27.3% |
| CONGO D REPULIC | $13.7K | 1 | 8.2% |
Mepro Pharmaceuticals Private Limited exports Pyrantel to 4 countries. The largest destination is CONGO accounting for 32.7% of Mepro Pharmaceuticals Private Limited's Pyrantel shipments, followed by CONGO, THE DEMOCRATIC REPUBLIC OF THE (31.8%) and CONGO THE DEMOCRATIC REPUBLIC OF THE (27.3%). These destinations reflect Mepro Pharmaceuticals Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pyrantel from Mepro Pharmaceuticals Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| M SSANTEVIE SARL | CONGO | $54.5K | 3 |
| M/S.SANTEVIE SARL | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $34.9K | 4 |
| M/S.SANTEVIE SARL, | CONGO, THE DEMOCRATIC REPUBLIC OF THE | $31.7K | 2 |
| M S SANTEVIE SARL | CONGO THE DEMOCRATIC REPUBLIC OF THE | $28.0K | 1 |
| 10 A.V.DE L'ACTION GOMBE KINSHAS | CONGO THE DEMOCRATIC REPUBLIC OF THE | $17.6K | 3 |
Mepro Pharmaceuticals Private Limited supplies Pyrantel to 5 buyers globally. The largest buyer is M SSANTEVIE SARL (CONGO), followed by M/S.SANTEVIE SARL (CONGO, THE DEMOCRATIC REPUBLIC OF THE) and M/S.SANTEVIE SARL, (CONGO, THE DEMOCRATIC REPUBLIC OF THE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pyrantel Export Value and How Much Does Mepro Pharmaceuticals Private Limited Contribute?
India exported $2.8M worth of Pyrantel through 477 shipments from 70 suppliers to 54 countries, serving 127 buyers globally. Mepro Pharmaceuticals Private Limited contributes $166.6K to this total, accounting for 5.1% of India's Pyrantel exports. Mepro Pharmaceuticals Private Limited ships Pyrantel to 4 countries through 5 buyers.
What Is the Average Shipment Value for Mepro Pharmaceuticals Private Limited's Pyrantel Exports?
Mepro Pharmaceuticals Private Limited's average Pyrantel shipment value is $12.8K per consignment, based on 13 shipments totaling $166.6K. The largest destination is CONGO (32.7% of Mepro Pharmaceuticals Private Limited's Pyrantel exports).
How Does Mepro Pharmaceuticals Private Limited Compare to Other Indian Pyrantel Exporters?
Mepro Pharmaceuticals Private Limited ranks #5 among 70 Indian Pyrantel exporters with a 5.1% market share. The top 3 exporters are KUSUM HEALTHCARE PRIVATE LIMITED ($736.8K), IPCA LABORATORIES LIMITED ($637.0K), OXFORD LABORATORIES PRIVATE LIMITED ($539.4K). Mepro Pharmaceuticals Private Limited processed 13 shipments to 3 destination countries.
What Pyrantel Formulations Does Mepro Pharmaceuticals Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMACEUTICAL PRODUCTS COMBAVERS TABLETS PYRANTEL TABLETS 125mg QTY 201430x1x6 s | $28.0K | 1 |
| PHARMACEUTICAL PRODUCTS: COMBAVERS TABLETS PYRANTEL TABLETS 125mg QTY:100210x1x6's | $18.4K | 1 |
| PHARMACEUTICAL PRODUCTS: COMBAVERS TABLETS PYRANTEL TABLETS 125mg QTY:100880x1x6's | $18.1K | 1 |
| PHARMACEUTICAL PRODUCTS: COMBAVERS TABLETS (PYRANTEL TABLETS 125MG) QTY:100370X1X6'S | $18.1K | 1 |
| PHARMACEUTICAL PRODUCTS: COMBAVERS TABLETS PYRANTEL TABLETS 125MG QTY:99970x1x6's | $18.0K | 1 |
| PHARMACEUTICAL PRODUCTS: COMBAVERS TABLETS (PYRANTEL TABLETS 125mg) QTY:100120x1x6'sNOS | $17.6K | 3 |
| PHARMACEUTICAL PRODUCTS: COMBAVERS TABLETS (PYRANTEL TABLETS 125MG) QTY:98760X1X6'S | $17.5K | 3 |
| PHARMACEUTICAL PRODUCTS: COMBAVERS (Pyrantel Tablets 125mg.) QTY:99800x1x6's | $17.4K | 1 |
| PHARMACEUTICAL PRODUCTS: COMBAVERS TABLETS (Pyrantel Tablets 125mg) QTY:96800x1x6's | $13.7K | 1 |
Mepro Pharmaceuticals Private Limited exports 9 distinct Pyrantel formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMACEUTICAL PRODUCTS COMBAVERS TABLETS PYRANTEL TABLETS 1 with 1 shipments worth $28.0K.
How Does Mepro Pharmaceuticals Private Limited Compare to Nearest Pyrantel Exporters?
Exporters ranked immediately above and below #5 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | OXFORD LABORATORIES PRIVATE LIMITED | $539.4K | 27 | 6 | $20.0K |
| 4 | SAVA HEALTHCARE LIMITED | $382.1K | 47 | 3 | $8.1K |
| 5 | MEPRO PHARMACEUTICALS PRIVATE LIMITED ★ | $166.6K | 13 | 3 | $12.8K |
| 6 | DEEPA INTERNATIONAL | $88.8K | 13 | 4 | $6.8K |
| 7 | VARDHMAN EXPORTS | $80.9K | 17 | 1 | $4.8K |
Mepro Pharmaceuticals Private Limited ranks #5 among 70 Indian Pyrantel exporters. Average shipment value of $12.8K compared to the market average of $40.5K. The closest competitors by value are OXFORD LABORATORIES PRIVATE LIMITED and SAVA HEALTHCARE LIMITED.
Which Indian Ports Ship Pyrantel Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 104 | 21.8% |
| JNPT | 66 | 13.8% |
| SAHAR AIR CARGO ACC (INBOM4) | 61 | 12.8% |
| NHAVA SHEVA SEA (INNSA1) | 53 | 11.1% |
| JNPT/ NHAVA SHEVA SEA | 38 | 8.0% |
| Bombay Air | 24 | 5.0% |
| NHAVA SHEVA SEA | 11 | 2.3% |
| HYDERABAD ICD | 10 | 2.1% |
What Other Antimalarial & Antiparasitic Products Does Mepro Pharmaceuticals Private Limited Export?
Mepro Pharmaceuticals Private Limited also exports these antimalarial & antiparasitic products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Mepro Pharmaceuticals Private Limited's Pyrantel Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Mepro Pharmaceuticals. The Israel-Iran conflict has disrupted Middle East trade routes, complicating logistics and increasing shipping costs. Additionally, Houthi attacks in the Red Sea have led major shipping lines, including Maersk and MSC, to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, effective February 1, 2025. These surcharges have significantly elevated the cost of trading with Europe and the US East Coast, compelling Indian exporters to absorb these costs or renegotiate terms with buyers. (sgeexport.com)
Conversely, the India–European Union Free Trade Agreement (India–EU FTA), concluded on January 27, 2026, offers a favorable development. This comprehensive agreement aims to liberalize trade and investment between India and the EU, potentially reducing tariffs and enhancing market access for Indian pharmaceutical products. For Mepro Pharmaceuticals, this could translate into increased export opportunities and a more competitive stance in the European market. (en.wikipedia.org)
In the United States, evolving import policies, including the imposition of additional tariffs under Section 232 of the US Trade Expansion Act, have impacted Indian exports. These tariffs affect products such as steel, aluminum, and auto components, totaling approximately $7.5 billion. While the direct impact on pharmaceutical exports is less pronounced, the overall trade environment necessitates strategic navigation to mitigate potential repercussions. (ipfonline.com)
Mepro Pharmaceuticals Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards remains a critical factor for Indian pharmaceutical exporters. The 2013 FDA bans on certain Indian pharmaceutical companies due to GMP non-compliance underscored the importance of stringent quality control measures. For Mepro Pharmaceuticals, maintaining adherence to FDA, WHO, and EU GMP standards is essential to ensure uninterrupted market access and to uphold the company's reputation in the global pharmaceutical industry. (comcec.org)
About Mepro Pharmaceuticals Private Limited
Mepro Pharmaceuticals Private Limited exports 11 products worth $17.5M. Beyond Pyrantel, top products include Albendazole, Hydrocortisone, Clotrimazole, Simvastatin, Zinc. View the complete Mepro Pharmaceuticals Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pyrantel — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pyrantel shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Mepro Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 13 individual customs records matching Mepro Pharmaceuticals Private Limited exporting Pyrantel, covering 9 formulations to 4 countries via 5 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 54+ countries, 127+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pyrantel Export Data from Mepro Pharmaceuticals Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Mepro Pharmaceuticals Private Limited's Pyrantel exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Mepro Pharmaceuticals Private Limited
Full Company Profile →
11 products · $17.5M total trade · 6 categories
Pyrantel Stats
Company Overview
Top Products by Mepro Pharmaceuticals Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Mepro Pharmaceuticals Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pyrantel. For current shipment-level data, contact TransData Nexus.